Educational only — not medical advice, not a diagnosis. This page describes what users commonly discuss with their licensed healthcare provider around this topic. We do not diagnose, treat, cure, reverse, or fix any condition. No compound listed is recommended. Work with a licensed clinician for any decision.
Home/Conditions/Andropause (Age-Related Testosterone Decline)
HORMONAL — EDUCATIONAL GUIDE

Andropause (Age-Related Testosterone Decline)

The gradual age-related decline in testosterone (~1% per year after 30) and the cluster of symptoms that sometimes accompanies it.

What This Is

Testosterone in men declines gradually starting around age 30, at roughly 1% per year. Whether this decline is symptomatic varies enormously — many men stay symptom-free into their 70s; others experience notable fatigue, libido decline, muscle loss, or mood changes in their 40s.

"Andropause" is a descriptive term, not a formal diagnosis. A clinical diagnosis of late-onset hypogonadism requires both symptoms AND repeatedly confirmed low lab values. Your licensed provider is the only source of that diagnosis.

Multiple evidence-based levers exist — lifestyle (resistance training, sleep, body composition, alcohol reduction), clinician-supervised HCG or enclomiphene for men wanting to preserve fertility, clinician-supervised TRT for men where natural axis restoration isn't working. Kisspeptin-10 is a research-stage upstream axis stimulator some users research. All of these are conversations with a licensed provider.

Biomarkers Users Commonly Track

The following lab markers are commonly discussed with a licensed provider in this context. They are not a diagnostic checklist. Only your clinician can interpret what these values mean for your specific situation.

Total Testosterone500–900 ng/dL is a common target in optimization practice
Baseline + serial tracking. Morning fasted draws.
Free Testosterone15–25 ng/dL on TRT; 10–20 ng/dL eugonadal
Bioavailable fraction — more informative in aging men with rising SHBG.
SHBG25–55 nmol/L is a common optimization target in men
SHBG rises with age and insulin sensitivity improvements; shifts free-T interpretation.
EstradiolMen: 20–35 pg/mL on TRT; premenopausal women: phase-dependent
Sensitive assay. Aromatization patterns shift with age + body comp.
LHMen: 4–8 mIU/mL when natural axis intact
Distinguishes primary from secondary causes.
FSHMen: 1.5–8 mIU/mL when fertile
Companion to LH.
DHEA-SUpper quartile for age — typically 300+ mcg/dL in 30s, 250+ in 40s
Adrenal androgen reserve declines with age.

Compounds Users Research (Ask Your Clinician)

No compound below is a recommended treatment. These are research-stage or investigational compounds that users commonly look up in this context. Any decision about their use is a conversation with a licensed healthcare provider, under their supervision, with full understanding of risks and your personal history.
kisspeptin-10
Research-stage upstream axis stimulator — discuss with clinician.

Related Reading

Related Conditions

Low TestosteroneChronic Fatigue / Low Energy
Bring the data to your next visit.

MyProtocolStack lets you log the biomarkers on this page across lab draws, chart the trend, and hand a structured report to your clinician. Better conversations start with better data. We do not replace your provider; we help you show up prepared.

Start tracking free →
Compliance notice: This page is informational and educational only. MyProtocolStack does not provide medical advice, diagnosis, or treatment. All references to biomarkers are educational. All references to compounds describe what users research and typically discuss with their clinician — not endorsements or treatment recommendations. Reference ranges vary by laboratory. Symptom interpretation and any protocol decisions require a licensed healthcare provider. If you are experiencing symptoms, consult your clinician.